NCT03537859 is a NA clinical trial of Augmented Reality in Hospitalized Child, sponsored by Universidad Peruana Cayetano Heredia.

Who is sponsoring NCT03537859?

NCT03537859 is sponsored by Universidad Peruana Cayetano Heredia.

What drugs are being tested in NCT03537859?

Interventions in NCT03537859: Augmented Reality, Non Augmented Reality.

What condition does NCT03537859 study?

NCT03537859 studies Hospitalized Child.

Is NCT03537859 still recruiting?

NCT03537859 is currently completed. Last updated 8 May 2019.

Last reviewed 2019-05-08 · How we verify

NCT03537859

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Effect of Augmented Reality Books on Cortisol Levels in Hospitalized Pediatric Patients

Completed NA Last updated 8 May 2019

What this trial tests

NA trial testing Augmented Reality in Hospitalized Child in 29 participants. Completed in 18 January 2019.

Timeline

5 June 2018

Primary endpoint
18 January 2019

18 January 2019

Quick facts

Lead sponsor	Universidad Peruana Cayetano Heredia
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	crossover
Masking	none
Primary purpose	other
Enrollment	29
Start date	5 June 2018
Primary completion	18 January 2019
Estimated completion	18 January 2019
Sites	1 location across Peru

Drugs / interventions tested

Augmented Reality
Non Augmented Reality

Conditions studied

Hospitalized Child — all drugs for Hospitalized Child →

Sponsor

Universidad Peruana Cayetano Heredia — full company profile →

Who can join

Adults 7 to 11, any sex, with Hospitalized Child. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Hospitalization is a stressful event that might impact in a patient's recovery. Children are more susceptible to suffer acute stress as a result of a hospital stay. Stress is often quantized using cortisol levels, a substance which increases following stressful stimuli. Since stress management is important in a patient's recovery, different therapies are used and have been evaluated and proven effective to diminish cortisol levels such as play interventions and clown therapy. Nevertheless, they rely on volunteers or trained staff to perform them. Nowadays, technology such as augmented reality allow us to provide therapy without the need of volunteers. This project aims to test if augmented reality technology is effective in lowering salivary cortisol levels in hospitalized children.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Augmented Reality

Trials testing the same drug.

NCT07112417 — "Augmented Reality-Assisted Miniscrew Placement in Orthodontics: A Clinical Trial" · NA · not yet recruiting
NCT07113093 — The Effects of Augmented Reality Versus Virtual Reality · NA · recruiting
NCT06761781 — Augmented Reality for Stroke Rehabilitation · NA · completed
NCT05885334 — Caregivers Training Using Artificial Intelligence and Virtual Reality · NA · completed
NCT06986655 — The Effect of an Augmented Reality Game on Pain, Fear, and Care Satisfaction Levels During Allergy Testing in Children A · NA · completed

Other Universidad Peruana Cayetano Heredia trials

Trials by the same sponsor.

NCT06367361 — One and Two Doses of Oxfendazole Versus a Schedule of Two Doses of Triclabendazole in Chronic Fascioliasis · Phase 2 · not yet recruiting
NCT06989502 — Implementation of the COmmunity HEalth System InnovatiON Project in Low- and Middle- Income Countries · NA · not yet recruiting
NCT06565507 — Oxfendazole in Mild Parenchymal Brain Cysticercosis · Phase 2, PHASE3 · not yet recruiting
NCT05981378 — Genomic Approaches to Dissect Human Host-pathogen Interactions in the Amazonian Rainforest · not yet recruiting
NCT06500013 — WhatsApp Intervention to Assess the Effect of Messages in Adherence to Antiretrovirals in Young People With HIV in Peru · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03537859 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universidad Peruana Cayetano Heredia
Last refreshed: 8 May 2019

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03537859.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing